Skip to main content
Clinical Trials/NCT00355680
NCT00355680CompletedPhase 3

Comparative Study of Indigenous Green Laser With Already Available Green Laser in Proliferative Diabetic Retinopathy

Aurolab1 site in 1 country24 target enrollmentStarted: December 1, 2005Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Aurolab
Enrollment
24
Locations
1
Primary Endpoint
Pigmentation of burn

Study Overview

Brief Summary

To Demonstrate that indigenous green laser produces similar treatment effect on the retina when compared with already available green laser.

Detailed Description

Proliferative Diabetic Retinopathy is ocular pathology in poor glycaemic controlled Diabetic patient Characterized by micro-vascular pathology with capillary closure in the retina leading to hypoxia of tissue there by formation of immature vessels to provide better oxygenation of retinal tissue.

In this randomized double blinded study a convenient sample size of 24 eyes assigned to compare indigenously developed green laser with already available green laser.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients more than 18 years of age
  • •Eyes with proliferative diabetic retinopathy requiring laser photocoagulation

Exclusion Criteria

  • •Eyes with media opacities not allowing proper fundus photography or adequate laser photocoagulation
  • •Patients requiring more than two sessions of laser photocoagulation
  • •Patients who had undergone previous laser photocoagulation
  • •Patients who had undergone any previous vitreo-retinal surgery

Arms & Interventions

1

Experimental

Aurolab Green Laser

Intervention: Green Laser (Aurolas, Aurolab) (Device)

2

Active Comparator

Available Green Laser

Intervention: Green Laser (Iridex) (Device)

Outcomes

Primary Outcomes

Pigmentation of burn

Time Frame: 2 months, 4 months, 6 months post laser

Lateral spread of burn

Time Frame: 2 months, 4 months, 6 months post laser

Regression of new vessels

Time Frame: 2 months, 4 months, 6 months post laser

Secondary Outcomes

  • Retinal detachment(2 months, 4 months, 6 months post laser)
  • Tractional retinal detachment(2 months, 4 months, 6 months post laser)
  • Bruch's membrane rupture(2 months, 4 months, 6 months post laser)
  • Choroidal detachment(2 months, 4 months, 6 months post laser)

Investigators

Sponsor
Aurolab
Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials